Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bb608 Compound
2. Bbi608
1. 83280-65-3
2. 2-acetylfuro-1,4-naphthoquinone
3. Bbi608
4. 2-acetylnaphtho[2,3-b]furan-4,9-dione
5. 2-acetylbenzo[f][1]benzofuran-4,9-dione
6. Bbi-608
7. Napabucasin (bbi608)
8. 2-acetylfuranonaphthoquinone
9. Z1hhm49k7o
10. 2-acetylnaphtho(2,3-b)furan-4,9-dione
11. Bbi 608
12. 2-acetyl-4h,9h-naphtho[2,3-b]furan-4,9-dione
13. Napabucasin [usan:inn]
14. Unii-z1hhm49k7o
15. Fnq
16. Napabucasin; Bbi608
17. Napabucasin [inn]
18. Napabucasin [jan]
19. Napabucasin [usan]
20. Napabucasin [who-dd]
21. Chembl64130
22. Napabucasin (jan/usan/inn)
23. Schembl1883845
24. Gtpl11358
25. Amy27812
26. Bcp07628
27. Ex-a1314
28. Bdbm50366597
29. Mfcd28155270
30. Nsc788900
31. Nsc816092
32. S7977
33. Zinc13306865
34. Akos027470201
35. Ccg-266871
36. Cs-1747
37. Db12155
38. Nsc-788900
39. Nsc-816092
40. 2-acetyl Naphtho2,3-bfuran-4,9-dione
41. Ac-32935
42. As-60519
43. Hy-13919
44. 2-acetyl-naphtho[2,3-b]furan-4,9-dione
45. A13474
46. D10717
47. F17379
48. Naphtho(2,3-b)furan-4,9-dione, 2-acetyl-
49. Q27294876
| Molecular Weight | 240.21 g/mol |
|---|---|
| Molecular Formula | C14H8O4 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 240.04225873 g/mol |
| Monoisotopic Mass | 240.04225873 g/mol |
| Topological Polar Surface Area | 64.4 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 414 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
80
PharmaCompass offers a list of Napabucasin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Napabucasin manufacturer or Napabucasin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Napabucasin manufacturer or Napabucasin supplier.
PharmaCompass also assists you with knowing the Napabucasin API Price utilized in the formulation of products. Napabucasin API Price is not always fixed or binding as the Napabucasin Price is obtained through a variety of data sources. The Napabucasin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BBI 608 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BBI 608, including repackagers and relabelers. The FDA regulates BBI 608 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BBI 608 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BBI 608 supplier is an individual or a company that provides BBI 608 active pharmaceutical ingredient (API) or BBI 608 finished formulations upon request. The BBI 608 suppliers may include BBI 608 API manufacturers, exporters, distributors and traders.
BBI 608 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BBI 608 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BBI 608 GMP manufacturer or BBI 608 GMP API supplier for your needs.
A BBI 608 CoA (Certificate of Analysis) is a formal document that attests to BBI 608's compliance with BBI 608 specifications and serves as a tool for batch-level quality control.
BBI 608 CoA mostly includes findings from lab analyses of a specific batch. For each BBI 608 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BBI 608 may be tested according to a variety of international standards, such as European Pharmacopoeia (BBI 608 EP), BBI 608 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BBI 608 USP).
